Major Companies in India Colorectal Cancer Market | Insights & Key Players 2026

Major Companies in India Colorectal Cancer Market

India colorectal cancer market is an expanding segment of the country’s oncology and healthcare diagnostics sectors, driven by rising colorectal cancer prevalence, increasing cancer screening awareness, and the adoption of advanced therapeutics. Key players in the market are Dr. Reddy's Laboratories, Biocon Limited, Lupin Limited, and Pfizer.

India Colorectal Cancer Market Overview

According to 6Wresearch, the India colorectal cancer market is witnessing strong growth due to an increasing incidence of colorectal cancer, expanding oncology infrastructure, and government initiatives promoting early diagnosis and treatment. The increasing adoption of immunotherapies, targeted therapies and minimally invasive surgical techniques further boost market expansion. Awareness campaigns and the growing network of specialized cancer centers support improved patient outcomes.

Competitive Landscape

The competitive landscape of the India colorectal cancer market is comprised of global pharmaceutical leaders and specialized domestic manufacturers. These companies provide a diverse range of products, including chemotherapeutic agents, targeted therapies, immunotherapies, diagnostic kits, and surgical instruments.

Leading Players Operating in the India Colorectal Cancer Market:

1. Dr. Reddy's Laboratories

A fast-growing leader in affordable oncology, Dr. Reddy's provides high-quality biosimilars and accessible therapeutic options that support large-scale cancer care in India.

2. Biocon Limited

Caters to the modern oncology workforce with a suite of sophisticated biological drug platforms that emphasize precision in tumor suppression and patient-centric care.

3. Lupin Limited

A pharmaceutical innovator that leverages cutting-edge research to provide high-precision oral oncology solutions for diverse patient demographics.

4. Natco Pharma

Provides high-volume processing and specialized cancer management solutions, supporting some of the largest private oncology centers in the country.

5. Glenmark Pharmaceuticals

Provides high-durability hardware processing and oncology drug management solutions, supporting some of the largest industrial health frameworks in the country.

6. Zydus Lifesciences

Focuses on the development of novel molecular entities and affordable generic oncology drugs that streamline patient access to colorectal cancer treatments.

7. Cipla Limited

A diversified conglomerate providing advanced chemotherapy agents and patient-support systems, supporting the widespread oncological needs of the Indian healthcare ecosystem.

8. Torrent Pharmaceuticals

Leverages advanced manufacturing capabilities to deliver high-quality generic oncology medications across the Indian domestic market.

9. Pfizer Inc.

A major force in the global oncology space, Pfizer focuses on developing innovative tyrosine kinase inhibitors and combination therapies for late-stage colorectal disease.

10. Merck KGaA

A historic innovator in medicine, Merck is renowned for its targeted epidermal growth factor receptor (EGFR) inhibitors, which are vital for personalized colorectal treatment protocols.

Major Companies in India Colorectal Cancer Market: FAQs